INCY PEER ANALYSIS

Incyte Corporation — metric-by-metric comparison with peers and the industry median

INCYIncyte Corporation

🇺🇸 USA · US · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

INCYIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	INCY	CSL	TLX	MSB	Ind. Median
P/E	17.05●	29.96	—	—	18.06
P/B	4.40	2.24●	6.38	—	3.62
EV/EBITDA	10.92	10.35●	120.20	—	15.13
P/S	4.55	2.66●	3.24	31.30	10.65

Financial Health
Metric	INCY	CSL	TLX	MSB	Ind. Median
Current Ratio	3.68●	2.57	1.43	—	5.90
Debt/Equity	0.6%●	67.4%	112.3%	—	10.9%
NetDebt/EBITDA	-2.13●	2.22	13.13	—	1.15

Profitability
Metric	INCY	CSL	TLX	MSB	Ind. Median
Net Margin	26.7%●	9.2%	-0.9%	-115.3%	-125.7%
ROE	31.1%●	7.7%	-1.8%	-11.3%	-47.5%
ROA	21.9%●	3.8%	-0.7%	-8.6%	-35.8%
EBITDA Margin	34.9%●	32.8%	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	INCY	CSL	TLX	MSB	Ind. Median
Rev. Growth	21.5%	4.8%	56.3%	410.4%●	5.1%
NI Growth	6,631.4%●	-39.4%	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	INCY	INSM	ROIV	MRNA	RPRX	JAZZ	Ind. Median
P/E	17.05●	—	—	—	39.08	555.19	18.06
P/B	4.40	34.49	6.51	4.25	4.70	3.61●	3.62
EV/EBITDA	10.92●	—	—	—	23.95	34.77	15.13
P/S	4.55	29.67	3,570.72	14.16	13.25	3.69●	10.65

Financial Health
Metric	INCY	INSM	ROIV	MRNA	RPRX	JAZZ	Ind. Median
Current Ratio	3.68	4.47	18.37●	2.41	2.66	2.04	5.90
Debt/Equity	0.6%●	106.2%	2.4%	17.5%	130.0%	119.5%	10.9%
NetDebt/EBITDA	-2.13●	0.44	16.03	1.35	4.91	4.67	1.15

Profitability
Metric	INCY	INSM	ROIV	MRNA	RPRX	JAZZ	Ind. Median
Net Margin	26.7%	-144.4%	-3,629.2%	-143.6%	33.9%●	0.7%	-125.7%
ROE	31.1%●	-294.5%	-6.5%	-36.6%	12.2%	0.7%	-47.5%
ROA	21.9%●	-61.0%	-5.4%	-26.4%	4.4%	0.3%	-35.8%
EBITDA Margin	34.9%	-131.9%	-3,162.6%	-129.7%	69.6%●	12.3%	-105.8%

Growth + Dividend
Metric	INCY	INSM	ROIV	MRNA	RPRX	JAZZ	Ind. Median
Rev. Growth	21.5%	115.1%●	-67.7%	-29.1%	7.8%	9.2%	5.1%
NI Growth	6,631.4%●	—	—	—	-24.3%	-93.9%	12.1%
Div. Yield	—	—	—	—	1.6%	—	0.2%
Payout	—	—	—	—	46.8%	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on INCY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.